EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access · CC BY-NC-ND 4.0

Efficacy of Morning Versus Evening Latanoprost/Timolol Fixed Combination for Open-Angle Glaucoma and Ocular Hypertension: A Randomized Clinical Trial

Hui Feng, Dong Han, Wensheng Lu, Guangxian Tang, Hengli Zhang, Sujie Fan, Aiguo Lv, Jing Jiang, Qing Zhang, Ye Zhang, Kai Cao, Zhi Li und 1 weitere

Translational Vision Science & Technology · 2024

DOI: 10.1167/tvst.13.1.21 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Translational Vision Science & Technology, 2024. Verfasst von Hui Feng und 12 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Tongren Eye Center, Beijing Tongren Hospital, Beijing Ophthalmology & Visual Science Key Lab, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Glaucoma, Open-Angle, Ocular Hypertension. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To compare the efficacy of morning and evening latanoprost/timolol fixed-combination (LTFC) dosing in patients with primary open-angle glaucoma (POAG) and ocular hypertension.

Methods

In this double-blind, randomized clinical trial, 63 untreated Chinese patients with POAG and ocular hypertension were enrolled. All patients received LTFC and were randomized (1:1) to group 1, morning (8 AM) dosing, or group 2, evening (8 PM) dosing. Vehicle drops were used in the morning or evening, accordingly, to preserve masking. Patients were treated for 4 weeks. Outcomes included mean reduction of the 24-hour intraocular pressure (IOP) and IOP fluctuation from baseline after a 4-week treatment.

Results

Fifty-six patients were included in the final analysis. In both groups, the posttreatment IOP values were significantly lower than those at baseline at each 24-hour measuring time point. A significant difference between the groups in IOP reduction from baseline was observed at the 9:30 AM time point (4.01 ± 2.62 vs. 2.42 ± 3.23 mm Hg, evening dosing versus morning dosing group; P = 0.048). Both groups showed decreased IOP fluctuation after treatment. However, the morning dosing group had a significantly greater decrease in diurnal IOP fluctuation than that of the evening dosing group (2.04 ± 2.32 mm Hg vs. 0.50 ± 1.70 mm Hg, respectively; P = 0.012).

Conclusions

Both morning and evening LTFC dosing can effectively reduce 24-hour IOP and IOP fluctuation. Morning dosing is more likely to effectively control diurnal IOP fluctuations. Translational Relevance: This multicenter, double-blind, randomized clinical trial generates robust evidence on the optimal LTFC dosing regimen to help clinical decision-making in the treatment of raised IOP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glaucoma, Open-AngleOcular HypertensionHumansIntraocular PressureLatanoprostTimololDouble-Blind Method

Substanzen

LatanoprostTimolol

Autor:innen und Institutionen

  • Beijing Tongren Eye Center, Beijing Tongren Hospital, Beijing Ophthalmology & Visual Science Key Lab, Capital Medical University, Beijing, China.
  • Department of Glaucoma, Hebei Eye Hospital, Xingtai, Hebei, China.
  • Department of ophthalmology, 1st Hospital of Shijiazhuang, Shijiazhuang, China.
  • Department of Ophthalmology, Handan 3rd Hospital, Handan, Hebei, China.
  • Department of Glaucoma, Fushun Eye Hospital, Fushun, China.
  • Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing, China.

Zitieren

APA

Feng, H., Han, D., Lu, W., Tang, G., Zhang, H., Fan, S., Lv, A., Jiang, J., Zhang, Q., Zhang, Y., Cao, K., Li, Z., & Li, S. (2024). Efficacy of Morning Versus Evening Latanoprost/Timolol Fixed Combination for Open-Angle Glaucoma and Ocular Hypertension: A Randomized Clinical Trial. Translational Vision Science & Technology. https://doi.org/10.1167/tvst.13.1.21

Vancouver

Feng H, Han D, Lu W, Tang G, Zhang H, Fan S, et al. Efficacy of Morning Versus Evening Latanoprost/Timolol Fixed Combination for Open-Angle Glaucoma and Ocular Hypertension: A Randomized Clinical Trial. Translational Vision Science & Technology. 2024. doi:10.1167/tvst.13.1.21

BibTeX
@article{Feng2024,
  author = {Feng, Hui and Han, Dong and Lu, Wensheng and Tang, Guangxian and Zhang, Hengli and Fan, Sujie and Lv, Aiguo and Jiang, Jing and Zhang, Qing and Zhang, Ye and Cao, Kai and Li, Zhi and Li, Shuning},
  title = {Efficacy of Morning Versus Evening Latanoprost/Timolol Fixed Combination for Open-Angle Glaucoma and Ocular Hypertension: A Randomized Clinical Trial},
  journal = {Translational Vision Science & Technology},
  year = {2024},
  doi = {10.1167/tvst.13.1.21}
}
Kostenlos starten →